Clinical effectiveness of Qilong capsule in patients with ischemic stroke: A prospective, multicenter, non-randomized controlled trial

Clinical effectiveness of Qilong capsule in patients with ischemic stroke: A prospective, multicenter, non-randomized controlled trial

Background: The Qilong capsule (QLC) is a Chinese patented medicine characterized by an equal emphasis on replenishing Qi and activating blood circulation. In 2000, China's FDA approved the use of QLC for ischemic stroke (IS). However, there is not yet much high-quality evidence of the clinical...

Full description

Bibliographic Details
Main Authors: Cai, Y. (Author), Chai, Y. (Author), Gao, Y. (Author), Lyu, J. (Author), Shen, X. (Author), Wei, R. (Author), Xie, Y. (Author), Yu, H. (Author), Zhao, D. (Author), Zhao, X. (Author)
Format: Article
Language:English
Published: Elsevier GmbH 2022
Subjects:
Chinese patent medicine
Clinical effectiveness
Generalized linear mixed model
Non-randomized controlled trial
Propensity score matching
Rank alignment transformation ANOVA
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items